The Company’s Board of Directors resolved to convene the 2024 Annual General Shareholders’ Meeting

1.Date of the board of directors resolution:2024/03/11
2.General shareholders’ meeting date:2024/06/17
3.General shareholders’ meeting location: Masterlink Securities Education and Training Center
(11F., No.97, Sec. 2, Dunhua S. Rd., Taipei City)
4.Shareholders meeting will be held by means of (physical shareholders
meeting/ visual communication assisted shareholders meeting /
visual communication shareholders meeting):physical shareholders meeting
5.Cause for convening the meeting I. Reported matters:
(1)2023 Business Report
(2)2023 Audit Committee’s Review Report
(3)Status of the Sound Operating Plan of the Company
(4)Amendments to the Company’s “Rules of Procedure for Board of
Directors Meetings”
6.Cause for convening the meeting II. Acknowledged matters:
(1)2023 Annual Final Accounting Ledgers and Statements
(2)2023 Earnings Distribution Loss Off-setting
7.Cause for convening the meeting III. Matters for Discussion:
(1)Amendment to the Company’s “Articles of Incorporation”
(2)Lifting of non-competition restrictions for the Company’s directors
8.Cause for convening the meeting IV. Election matters: None
9.Cause for convening the meeting V. Other Proposals: None
10.Cause for convening the meeting VI. Extemporary Motions: None
11.Book closure starting date:2024/04/19
12.Book closure ending date:2024/06/17
13.Any other matters that need to be specified:
Pursuant to Article 172-1 of the Company Act, the Annual General Meeting
will accept proposals by shareholders holding more than 1% of shares from
2024/4/8 to 2024/4/18. Shareholders shall submit the proposal with
applicable contact information before 5:00 pm on 2024/4/18 for the Board of
Directors to review and respond. (Please mark the letter “Proposal for
Annual General Meeting “ and send it by priority mail). Overdue will not be
accepted. Proposal receiving office is the Financial Department of OBI
Pharma Inc. (Address: 6th Floor, No. 508, Section 7, Zhongxiao East Road,
Taipei City, Tel: 02-26558799, ext. 115/157). The shareholders will be able
to exercise their voting rights electronically from 2024/5/18 to 2024/6/14.
The electronic voting system is managed by Taiwan Depository and Clearing
Corporation at